COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44980

Dr Souvik Maitra

souvikmaitra@live.com

2020-08-31

Not recruiting

RCT

Randomized

Parallel

Blind label

unclear

Treatment

Adult (aged between 18 and 65y) patients with laboratory confirmed SARS- CoV-2 infection with hypoxemia (defined by room air SpO2 â?¤ 94%) at the time of randomization will be included.

1. Refusal to participate <br/ >2. Mechanically ventilated patients <br/ >3. Patients with P/F ratio < 150 mm Hg <br/ >4. Patients with any known coagulation disorder <br/ >5. Patients with known platelet function disorder <br/ >6. Patients who are already on antiplatelet therapy <br/ >7. Patients with thrombocytopenia (platelet count < 100,000/ cmm) <br/ >8. Patients with any previous intracranial pathology <br/ >9. Patients with known gastric/ duodenal ulcer <br/ >10. Patients with history of gastro-intestinal bleeding within 3 months <br/ >11. Pregnancy women or women who are breastfeeding their children <br/ >12. Known allergy to aspirin <br/ >

2

Dr Souvik Maitra

18

65

India

Moderate/severe disease at enrollment

4: Moderate/severe disease at enrollment

60

To compare SpO2/ FiO2 ratio in day 1- 7 post randomization in both the groupsTimepoint: day 1- 7 post randomization

| Declared number of arm (2.0) differs from found arms (3.0)

Not reported

[{"arm_notes": "", "treatment_id": 129, "treatment_name": "Aspirin", "treatment_type": "Coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]